Fig. 2From: Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cellsTKIs inhibit TKs-mediated signaling pathway. TKIs inhibit tyrosine kinase, consequently interrupting the subsequent downstream signaling pathways, influencing cell proliferation and differentiation and leading to the arrest of cell growthBack to article page